Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 11,553 | 5,289 | 19,047 | 13,124 | 7,723 |
| Depreciation Amortization | 7,746 | 3,469 | 10,774 | 7,277 | 4,363 |
| Income taxes - deferred | -211 | -77 | -1,754 | -2,370 | -135 |
| Accounts receivable | -2,595 | -1,397 | -3,776 | -4,327 | -1,819 |
| Other Working Capital | 592 | 8,783 | -11,080 | -13,762 | -11,448 |
| Other Operating Activity | -5,355 | -2,163 | -13,477 | -8,674 | -6,316 |
| Operating Cash Flow | $11,730 | $13,904 | $-266 | $-8,732 | $-7,632 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -78,204 | -28,451 | -200,428 | -136,385 | -69,167 |
| Net Acquisitions | -14,566 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 43,975 | 22,157 | 113,402 | 83,332 | 46,118 |
| Other Investing Activity | 2,530 | 852 | 3,991 | 2,833 | 1,834 |
| Investing Cash Flow | $-46,265 | $-5,442 | $-83,035 | $-50,220 | $-21,215 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 55,500 | 17,500 | 138,100 | 101,000 | 51,000 |
| Debt Repayment | -1,164 | -31 | -38,025 | -436 | -349 |
| Common Stock Issued | N/A | N/A | 78,117 | 78,117 | 78,129 |
| Dividend Paid | N/A | N/A | -804 | -804 | -804 |
| Other Financing Activity | -10,340 | -284 | -106,019 | -126,329 | -109,959 |
| Financing Cash Flow | $43,996 | $17,185 | $71,369 | $51,548 | $18,017 |
| Exchange Rate Effect | 335 | 141 | 6 | 96 | 7 |
| Beginning Cash Position | 8,433 | 8,433 | 20,359 | 20,359 | 20,359 |
| End Cash Position | 18,229 | 34,221 | 8,433 | 13,051 | 9,536 |
| Net Cash Flow | $9,796 | $25,788 | $-11,926 | $-7,308 | $-10,823 |
| Free Cash Flow | |||||
| Operating Cash Flow | 11,730 | 13,904 | -266 | -8,732 | -7,632 |
| Capital Expenditure | -87,280 | -32,426 | -219,666 | -150,093 | -77,229 |
| Free Cash Flow | -75,550 | -18,522 | -219,932 | -158,825 | -84,861 |